| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $122.1M | +43.2% | +33.3% |
| R&D Expense | $22.5M | -3.9% | -24.7% |
| SG&A Expense | $21.9M | +30.4% | -39.3% |
| Operating Income | $75.5M | +66.6% | +194.4% |
| Pre-tax Income | $68.0M | +79.8% | +291.6% |
| Income Tax | $27.9M | +96.4% | +103.6% |
| Net Income | $40.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $140.4M | +51.2% | +59.2% |
| Accounts Receivable | $120.4M | +39.7% | +58.0% |
| Current Assets | $273.8M | +42.8% | +53.3% |
| Total Assets | $396.1M | +15.5% | +1.7% |
| Current Liabilities | $242.5M | +4.3% | +391.1% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $52.5M | — | — |
| Capital Expenditures | $35K | — | — |
| Investing Cash Flow | -$35K | — | — |
| Financing Cash Flow | $94K | — | — |
| Free Cash Flow | $52.4M | — | — |
| +69.8% |
| +999.3% |
| EPS (Basic) | $0.25 | +66.7% | +1150.0% |
| EPS (Diluted) | $0.23 | +64.3% | +1050.0% |
| $199.5M |
| +0.1% |
| +0.3% |
| Stockholders' Equity | -$264.2M | +14.3% | +15.2% |